Catalyst Wire Dossier Catalyst Wire Dossier

TERCONAZOLE VAGINAL CREAM 0.8%

terconazole · E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TERCONAZOLE VAGINAL CREAM 0.8%, covering 2010-12-30 to 2025-08-22. Get the full timeline:

Most recent: FDA Approved: TERCONAZOLE VAGINAL CREAM 0.8% — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

See pricing